Skip to main content Accessibility help

Login Alert

Cancel
Log in
×
×
Register
Log In
(0) Cart
Logo for Cambridge Core from Cambridge University Press. Click to return to homepage.
Logo for Cambridge Core from Cambridge University Press. Click to return to homepage.
Cited by
  • Crossref logo 8
  • Google Scholar logo
Crossref Citations
Crossref logo
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
DiStefano, Michael J. Levy, Joseph F. Odouard, Ilina C. and Anderson, Gerard F. 2023. Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations. Value in Health, Vol. 26, Issue. 11, p. 1618.
  • CrossRef
  • Google Scholar
Dumont, Rémy Lengliné, Etienne Delorme, Clara Bru, Jean-Pierre Ansart, Sévérine Aslangul, Elisabeth Kelley, Sophie Cochat, Pierre Chevret, Sylvie and Diatta, Thierno 2024. How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies. International Journal of Technology Assessment in Health Care, Vol. 40, Issue. 1,
  • CrossRef
  • Google Scholar
Gargano, Ludmila P. Alvares-Teodoro, Juliana de A. Acurcio, Francisco and Guerra, Augusto A. 2024. Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs. Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 24, Issue. 8, p. 977.
  • CrossRef
  • Google Scholar
Jommi, Claudio 2025. Formulating and Implementing Pharmaceutical Pricing Policies. p. 59.
  • CrossRef
  • Google Scholar
Perini, Martina Castiglioni, Beatrice Galai, Elisabetta Trapani, Dario Genazzani, Armando A and Miglio, Gianluca 2025. Differences in the on-label cancer indications of medicinal products between Europe and the USA. The Lancet Oncology, Vol. 26, Issue. 2, p. e103.
  • CrossRef
  • Google Scholar
Tomeczkowski, Jörg Heidbrede, Tanja Eichinger, Birte Osowski, Ulrike Leverkus, Friedhelm Schmitter, Sarah and Dintsios, Charalabos-Markos 2025. Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments. PharmacoEconomics,
  • CrossRef
  • Google Scholar
Del Grosso, Vittorio Perini, Martina Casilli, Giorgio Costa, Enrico Boscaro, Valentina Miglio, Gianluca and Genazzani, Armando A. 2025. Performance of the accelerated assessment of the European Medicines Agency. British Journal of Clinical Pharmacology, Vol. 91, Issue. 5, p. 1439.
  • CrossRef
  • Google Scholar
Yu, Seung‐Rae 2025. Improving the Reimbursement Process for New Drugs: A Case Study of a Two‐Waiver System in South Korea. Journal of Evaluation in Clinical Practice, Vol. 31, Issue. 3,
  • CrossRef
  • Google Scholar
Google Scholar Citations

View all Google Scholar citations for this article.

×
Cambridge University Press

Our Site

  • Accessibility
  • Contact & Help
  • Legal Notices

Quick Links

  • Cambridge Core
  • Cambridge Open Engage
  • Cambridge Aspire website

Our Products

  • Journals
  • Books
  • Elements
  • Textbooks
  • Courseware

Join us online

Please choose a valid location.

  • Rights & Permissions
  • Copyright
  • Privacy Notice
  • Terms of Use
  • Cookies Policy
Cambridge University Press 2025

Cancel
Confirm
×

Save article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Do France, Germany, and Italy agree on the added therapeutic value of medicines?
  • Volume 39, Issue 1
  • Giorgio Casilli (a1), Dario Lidonnici (a1), Claudio Jommi (a2), Marika De Nigris (a3) and Armando A. Genazzani (a2)
  • DOI: https://doi.org/10.1017/S026646232300048X
Please provide your Kindle email.
Available formats Please select a format to save.
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Do France, Germany, and Italy agree on the added therapeutic value of medicines?
  • Volume 39, Issue 1
  • Giorgio Casilli (a1), Dario Lidonnici (a1), Claudio Jommi (a2), Marika De Nigris (a3) and Armando A. Genazzani (a2)
  • DOI: https://doi.org/10.1017/S026646232300048X
Available formats Please select a format to save.
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Do France, Germany, and Italy agree on the added therapeutic value of medicines?
  • Volume 39, Issue 1
  • Giorgio Casilli (a1), Dario Lidonnici (a1), Claudio Jommi (a2), Marika De Nigris (a3) and Armando A. Genazzani (a2)
  • DOI: https://doi.org/10.1017/S026646232300048X
Available formats Please select a format to save.
×
×

Reply to: Submit a response

Contents help
Close Contents help

- No HTML tags allowed
- Web page URLs will display as text only
- Lines and paragraphs break automatically
- Attachments, images or tables are not permitted

Please enter your response.

Your details

Email help
Close Email help

Your email address will be used in order to notify you when your comment has been reviewed by the moderator and in case the author(s) of the article or the moderator need to contact you directly.

Please enter a valid email address.
You have entered the maximum number of contributors

Conflicting interests

Do you have any conflicting interests? * Conflicting interests help

Close Conflicting interests help

Please list any fees and grants from, employment by, consultancy for, shared ownership in or any close relationship with, at any time over the preceding 36 months, any organisation whose interests may be affected by the publication of the response. Please also list any non-financial associations or interests (personal, professional, political, institutional, religious or other) that a reasonable reader would want to know about in relation to the submitted work. This pertains to all the authors of the piece, their spouses or partners.